Impact of Hyperbilirubinemia Among HIV Patients Treated With Atazanavir

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

NCT01605084 ·Status: WITHDRAWN ·Phase: PHASE3

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

NCT00326716 ·Status: COMPLETED ·Phase: PHASE1

Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens

NCT00940771 ·Status: COMPLETED ·Phase: PHASE4

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

NCT01236235 ·Status: COMPLETED

Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects

NCT00096746 ·Status: COMPLETED

Effect of Atazanavir on Endothelial Function in HIV-Infected Patients

NCT00447070 ·Status: COMPLETED ·Phase: PHASE4

Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC

NCT01620944 ·Status: TERMINATED ·Phase: PHASE3

Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV

NCT00035932 ·Status: COMPLETED ·Phase: PHASE3

Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study

NCT00225017 ·Status: COMPLETED ·Phase: PHASE3

A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen

NCT00135447 ·Status: COMPLETED

Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment

NCT00757783 ·Status: COMPLETED ·Phase: PHASE4

Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir

NCT00120393 ·Status: COMPLETED ·Phase: PHASE3

Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)

NCT00028301 ·Status: COMPLETED ·Phase: PHASE3

Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With Cobicistat

NCT01837719 ·Status: COMPLETED ·Phase: PHASE1

BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes

NCT00389402 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetics of Atazanavir in Special Populations

NCT03923231 ·Status: COMPLETED

Pilot Study of a Raltegravir Based NRTI Sparing Regimen

NCT00814879 ·Status: COMPLETED ·Phase: NA

Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study

NCT02034838 ·Status: COMPLETED ·Phase: PHASE1

Phase IIB Pilot of Atazanavir + Raltegravir

NCT00768989 ·Status: TERMINATED ·Phase: PHASE2

A Study of a Nucleoside Sparing Regimen in HIV-1 Infected Patients With Detectable Viremia

NCT02542852 ·Status: COMPLETED ·Phase: PHASE2

Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir

NCT00365339 ·Status: COMPLETED ·Phase: PHASE1

A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor

NCT00028067 ·Status: TERMINATED ·Phase: PHASE3

A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic Syndrome

NCT00312754 ·Status: TERMINATED ·Phase: PHASE4

Study to Evaluate a HIV Drug for the Treatment of HIV Infection

NCT01803074 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating the Efficacy of a Reduced Dose Atazanavir in HIV-1-infected Patients

NCT02473328 ·Status: COMPLETED ·Phase: PHASE2